Leveraging AI for Knowledge Management in Pharmaceutical Development: The iQNow Experience at Boehringer Ingelheim
Information
During pharmaceutical product development, Boehringer Ingelheim generates hundreds of thousands of documents, each containing valuable knowledge and problem-solving strategies. _x000D_ _x000D_ _x000D_ The challenge is to make this knowledge accessible within the company to avoid redundant efforts. To address this, Boehringer Ingelheim developed iQNow, an AI-supported knowledge management system. iQNow employs various methods and technologies, with AI playing a crucial role, to deliver the right knowledge to the right person at the right time in a scalable, efficient, and universal manner. The introduction of GPT technology has been transformative for iQNow. In just nine months, the user base has grown to 26,000, and the system has enabled the reallocation of over 700,000 work hours to more productive activities._x000D_ _x000D_ _x000D_ In this conference, we will provide insights into the iQNow system and share our experiences of implementing AI in a large company._x000D_ _x000D_ _x000D_ Join us as we explore the intersection of AI and innovation within the context of pharmaceutical development in Germany.
